Abbott to Distribute Luminex MDx's Respiratory Panel Worldwide | GenomeWeb
NEW YORK (GenomeWeb News) – Abbott will be the sole distributor of Luminex Molecular Diagnostics’ respiratory viral panel outside of the United States, Luminex said today.
 
Under the agreement, Abbott will have exclusive rights to distribute the xTAG RVP outside of the US and semi-exclusive rights within the US, Luminex said.
 
The xTAG received 510(k) clearance from the US Food and Drug Administration in January 2008, and it was CE marked for sale in Europe in November 2006.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.